GlassScriptPhysician profile
Michael J Porter
NPI 1225074511
$3,069.39
in general payments reported to CMS, 2019-2025
22 companies · $484 in 2025
The $484 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $76.43 · 2021: $292 · 2022: $421 · 2023: $1,201 · 2024: $425 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316 · Travel and Lodging: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.77 |
| Travel and Lodging | $794.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $794.49 | 2023 | Carto 3 |
| Pfizer INC. | $461.60 | 2022-2025 | |
| Biosense Webster, INC. | $365.02 | 2023-2025 | Carto 3, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $342.82 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $267.91 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $150.20 | 2019-2024 | |
| Cardiva Medical, INC. | $88.72 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $85.81 | 2019-2023 | Watchman Access System |
| Biotronik INC. | $82.35 | 2025 | |
| Medtronic, INC. | $74.49 | 2021-2025 | Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.40 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $59.45 | 2022-2023 | Arcalyst |
| Esperion Therapeutics, INC. | $45.39 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $37.91 | 2020-2023 | Farxiga |
| Amgen INC. | $25.40 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.84 | 2022 | |
| Angiodynamics, INC. | $22.60 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.57 | 2023 | |
| Terumo Medical Corporation | $15.07 | 2019 | |
| Amarin Pharma, INC. | $14.53 | 2021 | |
| Elutia, INC. | $12.97 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.